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introduction: Left atrial pulmonary vein isolation (PVI) is an accepted treatment option 
for patients with symptomatic atrial fibrillation (AF). This procedure can be complicated 
by stroke or silent cerebral embolism. Online measurement of microembolic signals 
(MESs) by transcranial Doppler (TCD) may be useful for characterizing thromboembolic 
burden during PVI. In this prospective multicenter trial, we investigated the burden, 
characteristics, and composition of MES during left atrial catheter ablation using a variety 
of catheter technologies.
Materials and methods: PVI was performed in a total of 42 patients using the 
circular-shaped multielectrode pulmonary vein ablation catheter (PVAC) technology in 
23, an irrigated radiofrequency (IRF) in 14, and the cryoballoon (CB) technology in 5 
patients. TCD was used to detect the total MES burden and sustained thromboembolic 
showers (TESs) of >30 s. During TES, the site of ablation within the left atrium was reg-
istered. MES composition was classified manually into “solid,” “gaseous,” or “equivocal” 
by off-line expert assessment.
results: The total MES burden was higher when using IRF compared to CB 
(2,336 ± 1,654 vs. 593 ± 231; p = 0.007) and showed a tendency toward a higher 
burden when using IRF compared to PVAC (2,336 ± 1,654 vs. 1,685 ± 2,255; p = 0.08). 
TES occurred more often when using PVAC compared to IRF (1.5 ± 2 vs. 0.4 ± 1.3; 
p = 0.04) and most frequently when ablation was performed close to the left superior 
pulmonary vein (LSPV). Of the MES, 17.004 (23%) were characterized as definitely solid, 
13.204 (18%) as clearly gaseous, and 44.366 (59%) as equivocal.
Discussion: We investigated the burden and characteristics of MES during left atrial 
catheter ablation for AF. All ablation techniques applied in this study generated a 
Abbreviations: ACT, activated clotting time; AF, atrial fibrillation; CB, cryoballoon; IRF, irrigated radiofrequency; LIPV, 
left inferior pulmonary vein; LSPV, left superior pulmonary vein; MESs, microembolic signals; PVAC, pulmonary vein 
ablation catheter; PVI, pulmonary vein isolation; PV, pulmonary vein; RIPV, right inferior pulmonary vein; RSPV, right 
superior pulmonary vein; SCE, silent cerebral embolism; TCD, transcranial Doppler; TESs, thromboembolic showers.
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relevant number of MES. There was a significant difference in total MES burden using 
IRF compared to CB and a tendency toward a higher burden using IRF compared to 
PVAC. The highest TES burden was found in the PVAC group, particularly during abla-
tion close to the LSPV. The composition of thromboembolic particles was balanced. 
The impact of MES, TES, and composition of thromboembolic particles on neuro-
logical outcome needs to be evaluated further. (Clinical Trial Registration: Deutsches 
Register Klinischer Studien, https://drks-neu.uniklinik-freiburg.de/drks_web/navigate.
do?navigationId=trial.HTML&TRIAL_ID=DRKS00003465. DRKS00003465.)
Keywords: catheter ablation, stroke, atrial fibrillation, microemboli, transcranial Doppler
inTrODUcTiOn
Left atrial catheter ablation leading to electrical pulmonary 
vein isolation (PVI) is a corner stone therapy for patients with 
symptomatic atrial fibrillation (AF). PVI targets and eliminates 
potential electrical triggers of AF located inside the pulmonary 
veins (PVs). The success rate depends on the type of AF and 
ranges from 50 to 80% (1). PVI is considered to be a safe procedure 
when performed by an experienced cardiologist. However, 
clinically apparent stroke is a fatal complication of this procedure 
with an incidence of up to 1% (1). More frequently, silent cerebral 
embolism (SCE) measured by diffusion-weighted MRI (DWI-
MRI) has been shown to be a clinically unapparent thromboem-
bolic complication following PVI (2–4). In addition, occurrence 
of SCE has been linked to different ablation strategies, whereby 
the pulmonary vein ablation catheter (PVAC) technology seemed 
to provoke the highest incidence of new DWI lesions (2–6).
Real-time measurement of microembolic signals (MESs) by 
transcranial Doppler (TCD) is an accepted online biomarker for 
thromboembolic complications (7–11). So far, microembolus 
detection using transcranial Doppler (MES-TCD) has been tested 
in the setting of cardiac disease (i.e., AF), but it has also been used 
to measure the microembolic burden during invasive procedures 
(7, 8, 10). Recently, MES monitoring by TCD was also used as 
a surrogate marker for stroke risk during left atrial catheter abla- 
tion for AF (5, 6, 12, 13).
However, the data on the quantity and quality of MES dur-
ing PVI are sparse. In this multicenter trial, we investigated the 
associated burden, characteristics, and composition of MES 
during left atrial catheter ablation and compared the different 
catheter techniques [PVAC, irrigated radiofrequency (IRF), and 
cryoballoon (CB)].
MaTerials anD MeThODs
study Design and subject 
characteristics
This observational, non-randomized, prospective trial was per-
formed at three institutions—Department of Internal Medicine 
II, University Hospital Regensburg, Department of Electro-
physiology, Bad Neustadt, and Department of Cardiology and 
Angiology, Heart Center Bad Krozingen—between July 2011 
and November 2012. Ethics approval was obtained from the 
University of Regensburg (No. 11-101-0134) before the trial 
commenced, and the study was registered with an international 
trial registry in Freiburg, Germany (Deutsches Register Klinischer 
Studien, No. DRKS00003465). Only patients with AF who were 
scheduled for PVI alone were included in the study. The main 
exclusion criteria were patient age of <18 and >80 years, chronic 
neurological disease, diagnosis of dementia, prior left atrial 
ablation, severe claustrophobia, and implanted cardiac devices 
(contraindicated for MRI). Informed written consent was 
obtained from all patients before inclusion in the study.
ablation Procedure and Techniques
According to each center’s preference, three different ablation 
techniques (PVAC, IRF, and CB) were applied to achieve PVI. 
All techniques were performed in a standardized manner 
and have been described previously (4). Oral anticoagulation 
(OAC) therapy was required for at least 4  weeks prior to the 
procedure to minimize the risk of left atrial thrombus. Ablation 
was performed under continuous OAC therapy (INR > 2 when 
using Coumadin). During the study period, a new orally 
administered direct thrombin inhibitor (dabigatran etexilate, 
Pradaxa®, Boehringer Ingelheim, Ingelheim, Germany) was 
approved for anticoagulation in patients with non-valvular 
AF; patients taking this drug were regarded as having full 
anticoagulation. During the procedure, an activated clotting 
time (ACT) level >300  s was required. All patients received 
transesophageal echocardiography to rule out the presence of 
left atrial thrombus formation.
Ablation with the PVAC
Phased RF ablation was performed using the Pulmonary Vein 
Ablation Catheter® technology (PVAC, Medtronic, Minneapolis, 
MN, USA). After transseptal access had been obtained, a 12-French 
steerable sheath was placed. The sheath was flushed throughout 
the procedure, with maximum flushing occurring during the 
process of loading and unloading the PVAC. Ablation was started 
when the ACT was >300  s and was performed using either a 
4:1, 2:1, or 1:1 energy mode for 60 s per application with a target 
temperature of 60°C. PVAC ablation was continued until isolation 
of each PV was successful; this was confirmed by an entrance 
block using differential pacing and by evidence of an exit block. 
It is important to note that the PVAC procedure was not performed 
according to ERACE criteria (14). Selection of the energy mode, 
electrode pairs, and the interruption of energy delivery were made 
according to the initial protocol and each center’s preference. 
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In addition, Genius 14.3 software without PVAC gold technology 
was employed.
Irrigated Radiofrequency (IRF) Ablation
Conventional PVI was performed using an irrigated-tip catheter 
(NaviStar Thermocool or SmartTouch, Biosense Webster, Dia- 
mond Bar, CA, USA) and a deflectable, decapolar mapping cath-
eter (Lasso-NAV, Biosense Webster). After transseptal access had 
been obtained, the geometry of the left atrium was constructed 
by three-dimensional FAM mapping with the Carto 3 System 
(CARTO™, Biosense Webster). Point-by-point irrigated radio-
frequency ablation was performed to encircle the right and left 
PVs in pairs. The end-point of the procedure was the electrical 
isolation of all PVs, which was confirmed by the entrance block 
and differential pacing. No further ablations were carried out in 
the left atrium.
Ablation with CB
One single transseptal puncture was made, after which a steerable 
sheath (Flexcath, Medtronic CryoCath LP, Pointe-Claire, QC, 
Canada) was placed in the left atrium. Ablation was performed 
using a double-coated over-the-wire CB (Arctic Front, Medtronic). 
The inner lumen of the CB was connected to a continuous pres-
sure monitoring system. Balloon size was selected in accordance 
with the diameters of the PVs, as measured by transesophageal 
echocardiography. In general, a 28-mm balloon was used. The 
deflated CB was advanced and inflated in front of the venous 
ostium. After inflation, the balloon was advanced to achieve 
occlusion of the PV. Occlusion was verified by application of a 
contrast agent. Each PV was frozen twice over 5 min in the best 
position for occlusion. During ablation of the right PVs, continu-
ous phrenic nerve pacing was performed from the superior vena 
cava to promptly detect phrenic nerve injury. If the PV dimen-
sions were too heterogeneous, the size of the balloon was modified 
to ensure proper occlusion. In case of persistent conduction after 
CB ablation, electrical isolation was completed segmentally.
Microembolus Detection Using TD
At all centers, MES-TCD was performed during the ablation 
procedure using the same equipment (Doppler Box, DWL, 
Germany). A teaching session was held prior to study initiation. 
Continuous bilateral insonation in the middle cerebral artery 
(MCA) territory was attempted with the patient in supine posi-
tion for cardiac intervention. In accordance with the interna-
tional consensus recommendations, the sample gate was 8 mm 
and the Doppler gain was reduced to exhibit only faint Doppler 
spectra.
Blinded off-line analysis of the recorded MES-TCD data 
was performed in a single center by two different neurologists 
familiar with the technique according to standard criteria (15). 
In previous studies, application of the implemented gaseous/solid 
differentiation and detection algorithm was found to be unreli-
able, probably due to the magnitude and dense number of signals 
as well as frontend overload (16–18). Thus, manual analysis of 
MES comprised (i) listening to each signal and (ii) watching each 
signal on screen at highest speed. Ratings were made without 
using a decibel threshold. Single countable MES were summed 
up to a total MES count. Definitely “solid” emboli were strictly 
unidirectional within the Doppler spectrum and had an acoustic 
impedance >8 dB over baseline. Clearly “gaseous” emboli were 
characterized as large and high-intense bidirectional signals 
exceeding the Doppler spectrum probably due to stimulated 
acoustic emission from bubble bursts by the incident ultrasound 
wave (19). When signals did not meet the strict criteria for solid 
or gaseous emboli they were classified as “equivocal.” In addition, 
periods with a huge amount of MES lasting longer than 30 s were 
classified as thromboembolic shower (TES) (Figure  1), as this 
phenomenon may be associated with a higher risk for cerebral 
damage. To determine the impact of the ablation site on occur-
rence of TES, appearance of TES was assigned to the ablated PV 
[left superior pulmonary vein (LSPV), left inferior pulmonary 
vein (LIPV), right superior pulmonary vein (RSPV), and right 
inferior pulmonary vein (RIPV)].
core lab analysis and clinical Follow-up
All data were collected by each center and sent to the University 
Hospital Regensburg for core lab analysis. Off-line analysis of 
the recorded MES-TCD data was performed as described above 
by two neurologists. Clinical neurological events were monitored 
during the patients’ stay in hospital.
statistical analysis
Non-parametric statistical methods were applied in an explora-
tory manner using SAS®, release 9.3 (SAS Institute Inc., Cary, 
NC, USA) on a Microsoft® Windows® 7 Professional platform. 
The alpha level for testing was set to 5%, two-sided without 
correction for multiplicity. Summary statistics were determined. 
The Wilcoxon rank sum test was carried out for pairwise group 
comparison of events. In addition, a potential difference in 
number of TES events with regard to the site of ablation was 
investigated using the Wilcoxon signed rank test. Furthermore, 
for the investigation of categorical variables Fisher’s exact test 
was used. Homogeneity between groups was investigated using 
the non-parametric Kruskal–Wallis test for continuous variables. 
This was done taking the ablated structure in each patient into 
account. The bar charts show the median values or mean values 
if the group-wise median values are equal to 0.
resUlTs
Patient characteristics
Between July 2011 and November 2012, 42 patients were eligible 
for TCD analysis. Table 1 shows the patient characteristics and 
clinical baseline parameters according to the ablation technique 
used.
ablation Procedure
Pulmonary vein isolation was performed using PVAC in 23 
patients, IRF in 14 patients, and CB in 5 patients. The mean length 
of the procedure was 174 ±  77  min in the phased RF (PVAC) 
group, 153 ± 48 min in the IRF group, and 169 ± 12 min in the 
CB group; the mean fluoroscopy time was 38 ± 21, 26 ± 9, and 
20 ± 7 min, respectively. The mean number of energy deliveries 
FigUre 1 | Transcranial Doppler data and typical characteristics of microembolic signal. (a) Solid emboli: stays within the Doppler spectrum,  
multigating confirms movement through different depths. (B) Gaseous emboli: exceeds the Doppler spectrum, biphasic, multigating reveals signals at one  
depth only. (c) Equivocal emboli: exceeds the Doppler spectrum, but unidirectional, multigating reveals signals at one depth only. (D) Thrombembolic shower: 
signals move at low velocity, continuous embolic activity, oblique multigated signals reveal movement at different depths.
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for successful isolation of all PVs was 24 ± 10 using PVAC, 52 ± 38 
using IRF, and 9 ±  2 using CB (p <  0.001). When using the 
PVAC, the 2:1 energy setting was employed more frequently 
than the 4:1 mode (n =  363 vs. n =  169). Complete isolation 
could be achieved in all PVs. No additional left atrial ablation 
was performed. Table  1 shows the procedural parameters for 
each ablation technique.
Mes count and Differentiation
Bilateral insonation of the MCA was feasible in n = 35 patients. 
In n = 7 patients, for technical reasons, only unilateral insona-
tion could be achieved. Unilateral insonation was present in six 
patients treated with PVAC technology at the University Hospital 
of Regensburg and in one patient treated with CB at the Heart 
Center Bad Neustadt. A total of 74.574 MES were recorded in 
42 patients during the ablation procedures. Of those, 17.004 
(23%) MES were characterized as solid, 13.204 (18%) as gase-
ous, and 44.366 (59%) as equivocal. There was a high variation 
in the number of MES per patient (lowest with n =  21 up to 
n = 8,317). Figure 2 shows the median values of MES and the 
MES subdivision related to the different ablation techniques. 
Wilcoxon rank sum test indicates a significantly lower incidence 
of total and equivocal MES in the CB group compared to the 
IRF group. Pairwise comparison of the remaining cases did not 
reach statistical significance. However, there was a tendency 
toward lower MES burden (total and solid) in the PVAC group 
compared to the IRF group (Table  2). When using the PVAC, 
MESs usually occurred 10–15 s after energy delivery had started. 
We also observed MESs when manipulating/rotating the PVAC 
after termination of energy delivery.
Tes and assignment to ablation site
A total of 42 TESs were registered in 12 different patients during 
the ablation procedures. The majority of the TESs (n = 35 in 10 
patients) were recorded in the PVAC group. Only seven TESs were 
found in two patients in the IRF group and no TESs were regis-
tered in the CB group (Figure 3). Pairwise comparison showed a 
significantly higher TES burden in the PVAC group compared to 
the IRF group. There was a tendency toward a lower TES burden 
in the CB group compared to the PVAC group, which was not sta-
tistically significant (Table 2). Observing the occurrence of TESs 
pertaining to the ablation site, we found a significantly higher 
rate of TES when ablating the LSPV compared to the left infe- 
rior pulmonary vein and right inferior pulmonary vein (Figure 4).
clinical Outcome
None of the patients suffered a clinical stroke during their hospital 
stay; this also applied to the patient with the highest (n = 8,317) 
TaBle 1 | Table shows baseline and procedural (italics) parameters.
Baseline/procedural 
parameters
Pulmonary 
vein 
ablation 
catheter 
(PVac)
irF cryoballoon 
(cB)
p Value
Patients (n) 23 14 5 –
Sex male/female 13/10 11/3 4/1 0.41
Mean age 68 ± 8 65 ± 7 63 ± 17 0.53
Atrial fibrillation (AF) type 
paroxysmal/chronic (n)
21/2 8/6 2/3 0.01
Coronary artery disease (n) 5 3 0 0.73
Hypertension (n) 13 11 3 0.38
Left ventricular hypertrophy 
(n)
7 2 4 0.02
Diabetes (n) 4 1 0 0.81
Left ventricular ejection 
fraction (%)
58 ± 6 56 ± 7 60 ± 5 0.72
Mean left atrial diameter 
(mm)
44 ± 6 44 ± 12 39 ± 4 0.25
Type of oral anticoagulation 
(Coumadin/Dabigatran)
16/7 12/2 5/0 0.36
Ablations performed 
at University Hospital 
Regensburg
23 3 0
Ablations performed at Heart 
Center Bad Krozingen
0 5 0 <0.0001
Ablations performed at Heart 
Center Bad Neustadt
0 6 5
Bilateral insonation (yes/no) 
of middle cerebral artery
17/6 14/0 5/1 0.08
Total procedure time (min) 174 ± 77 153 ± 48 169 ± 12 0.74
Fluoroscopy time (min) 38 ± 21 26 ± 9 20 ± 7 0.36
Energy applications (n) 24 ± 10 52 ± 38 9 ± 2 0.001
Power (W) – 36 ± 4 – –
Temperature (°C) – 43 ± 4 – –
Homogeneity between groups was investigated using the non-parametric Kruskal–
Wallis test for continuous variables and Fisher’s exact test for categorical variables. 
There was a significant difference regarding AF type, left ventricular hypertrophy, 
employed ablation technique/center, and number of energy applications.
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MES burden. However, one patient in the PVAC group reported 
a subjective visual disturbance lasting several seconds, which 
was assessed as a migraine with aura. This patient had a low total 
MES burden (n = 174) and one TES.
DiscUssiOn
Evidence of SCE illustrated by DWI-MRI has drawn attention 
to an important feature of clinically asymptomatic neurological 
complications following PVI. The use of the PVAC, in particular, 
seemed to provoke a high incidence of new DWI lesions (2, 3). 
However, cerebral MRI only documents thromboembolic events 
after and not during the ablation procedure. Online measure-
ment of MESs by TCD is a useful tool for learning more about 
the thromboembolic burden during left atrial catheter ablation. 
So far, there are little data available on this subject.
This multicenter study investigated the burden and charac-
teristics of MES during PVI using three different ablation tech-
niques. The results show that: (i) all ablation techniques applied 
in this study generated a relevant number of MESs. The total 
MES burden was significantly higher in the IRF group compared 
to the CB group and showed a tendency toward a higher bur-
den in the IRF group compared to the PVAC group. (ii) TESs 
occurred more often in the PVAC group compared to the IRF 
group. In the small number of patients treated with CB, no TESs 
were observed. TESs were seen most frequently when ablation 
was performed close to the LSPV. (iii) This study provides the 
first data on subdivision of MES (gaseous vs. solid vs. equivo-
cal) by manual and not automated analysis, showing a balanced 
distribution of solid and gaseous MES burden.
Our study adds to the findings on total thromboembolic bur-
den and is in line with previous studies demonstrating a lower 
total MES count in the CB group and a higher MES burden when 
using IRF or the PVAC with an initial protocol (6, 13, 20, 21). 
MESs were observed during energy delivery as well as during 
catheter manipulation immediately after ablation. Remarkably, 
our study even shows a higher MES burden by trend in the 
IRF group compared to the PVAC group. This is in contrast to 
previous studies, which demonstrated a median MES ranging 
from 646 ± 449 to 1,404 ± 98 in the IRF group (13, 20). By com-
parison, the median MES burden in the IRF group in our study 
(2,336 ± 1,654) was high. This may be attributed to the higher 
number of energy applications, the maximum power, and maxi-
mum energy settings used in our study. These parameters seem 
to correlate with MES burden and upper values may be respon-
sible for a higher MES count (13). In addition, Kochhäuser et al. 
(20) found more MES during catheter replacement in the IRF 
group compared to the PVAC group, which might have been a 
relevant factor in the present study. However, our finding strongly 
emphasizes the need to reduce MES when using the IRF or PVAC 
technology.
Although MES burden was higher in the IRF group we found 
more TES when using the PVAC technology compared to IRF. 
In the small number of patients in the CB group, we found no 
TES. As TES potentially may cause cerebral damage to a greater 
extent, this finding may correspond to the higher incidence 
of SCE measured by MRI following PVAC ablation (2, 3) and 
supports the attempt to reduce embolic signals by deactivation 
of the distal electrodes, optimizing catheter-tissue contact, and 
employment of the newest Genius generator software (6, 22). 
Interestingly, TES occurred mainly when ablating at the region 
of the LSPV. This is in line with the study conducted by Nagy-
Balo et al. (23) who found more MES during ablation close to the 
left-sided PVs. Proximity of the LAA creating a complex anatomy 
between LSPV and the ridge and/or a steep catheter position 
based on the direction of the inferior caval vein and transseptal 
access may lead to alternating contact force and/or to an overlap 
of electrodes 1 and 10 during PVAC procedures. These conditions 
are known mechanisms of microembolization and may increase 
the incidence of TES.
The composition of the thromboembolic burden may be a 
relevant factor pertaining to cerebral damage, as gaseous MES 
might be less harmful than solid particles. Thus, subdivision of 
MES into gaseous and solid may be of diagnostic relevance. Only 
a small number of studies identify gaseous particles as the main 
source of microembolization during left atrial catheter ablation 
(6, 21). However, the subdivision was done using an automated 
algorithm, which has not yet been sufficiently evaluated for 
TaBle 2 | Total microembolic signal (Mes) burden, Mes differentiation, and thromboembolic shower (Tes) burden are represented as median  
and mean values.
Pulmonary vein ablation 
catheter (PVac)
irF cryoballoon (cB) PVac vs. irF PVac vs. cB irF vs. cB
Pts. (n) 23 14 5 – – –
MES total median/mean ± SD 602/1,685 ± 2,255 2,009/2,336 ± 1,654 545/593 ± 231 p = 0.08 p = 0.81 p = 0.007
MES solid median/mean ± SD 147/330 ± 593 293/628 ± 770 82/135 ± 137 p = 0.08 p = 0.45 p = 0.13
MES gaseous median/mean ± SD 208/360 ± 511 187/327 ± 386 119/106 ± 67 p = 0.84 p = 0.13 p = 0.20
MES equivocal median/mean ± SD 74/994 ± 1,448 1,439/1,380 ± 799 345/351 ± 213 p = 0.12 p = 0.71 p = 0.01
Pts. with TES (n) 10 2 0 – – –
TES median/mean ± SD 0/1.5 ± 2 0/0.4 ± 1.3 0/0 p = 0.04 p = 0.08 p = 0.61
P values are based on the non-parametric Wilcoxon rank sum test for pairwise comparison between the ablation groups. P values are calculated by pairwise comparison  
between the ablation groups.
Pts., patients.
FigUre 2 | Boxplot shows median values of total microembolic signal (Mes) burden and subdivision of Mes according to the different ablation 
techniques.
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precision (16–18). Performing a manual analysis, we found a 
homogeneous distribution of solid and gaseous MESs, in which 
IRF shows a tendency to elicit more solid particles compared 
to PVAC. Solid particles may occur due to charring and a more 
aggressive ACT target during ablation could reduce the solid 
component. However, current studies evaluating this issue did 
not reach statistical significance and thus the anticoagulation 
protocol in TCD studies needs to be evaluated further (21).
Importantly, the impact of documented MES during PVI on 
neurological outcome is still unclear. Kilicaslan et al. report an 
acute neurological complication rate of 36% in patients with MES 
>3,000 (12). Another study found a correlation of MES with a 
subtle neuropsychological deficit post ablation (20). None of the 
patients in our study, even those with MES >3,000 (n = 7), suf-
fered a clinical stroke during their stay in hospital. One patient 
with migraine episode showed only a low MES burden. Thus, the 
potential context of MES and neurological impairment should 
be investigated more extensively.
As clinically unapparent thromboembolic events may be a 
potential complication of PVI, the indication for left atrial cath-
eter ablation has to be considered properly. However, even in the 
light of thromboembolic risk, PVI remains an important treat-
ment option for patients with symptomatic AF, as AF burden can 
severely impair the quality of life. There is need for further studies 
elaborating the risk of stroke during the ablation procedure.
limitations
This study has several limitations: (1) we performed a non-
randomized study with a small sample size in the CB group which 
hampers the possibility to draw firm conclusions concerning the 
FigUre 4 | Thromboembolic shower (Tes) burden related to the ablation site. When ablating the left superior pulmonary vein (LSPV), the burden  
of TES at this site was significantly higher compared to the left inferior pulmonary vein (LIPV) and right inferior pulmonary vein (RIPV).
FigUre 3 | The burden (n) of thromboembolic shower (Tes) in each patient related to the ablation technique. TES were found in 10 patients of  
the pulmonary vein ablation catheter (PVAC) group and in 2 patients of the IRF group. No TES were seen in the cryoballoon (CB) group.
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employed CB technology. CB ablation was an upcoming technol-
ogy during the study period and was not routinely performed at 
all study centers. Hence, the study protocol did not pretend the 
catheter technology to allow for the best expertise at each study 
center. This generated a small number in the CB cohort, limit-
ing statistical testing pertaining to this group. It is also unclear 
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whether TES would have occurred if the CB patient cohort was 
larger. Focusing on MES alone, our CB data are in line with other 
studies and should not be withheld. (2) According to the non-
randomized character of this study, variables as AF type (PAF/
CAF), left ventricular hypertrophy, employed ablation technique/
center, and number of energy applications were not equally 
distributed in the different groups, which creates heterogeneity 
and may influence the burden of MES/TES during the procedure. 
(3) MES in patients with unilateral insonation was not counted 
differently to not witheld this data. However, this may be a source 
of bias, as MES of the contralateral side is not incorporated in 
these patients. (4) MES is registered during the entire ablation 
procedure without discriminating energy delivery from catheter 
manipu-lation or transseptal puncture. Thus, no assignment of 
MES to single steps of the procedure can be made. However, 
“time stamping” is available for TES recording. (5) The standard 
evaluation of MES is off-line assessment by an expert (17), but 
the human factor of manual analysis in our study needs to be 
considered.
cOnclUsiOn
The present study demonstrates a significant difference in total 
MES burden using IRF compared to CB and a tendency toward 
a higher burden using IRF compared to PVAC. This highlights 
the need to reduce MES also when using devices other than the 
PVAC, i.e., IRF. The most intense TESs, indicating a severe and 
sustained thromboembolic burden, were found in the PVAC 
group, particularly during ablation close to the LSPV. The 
thromboembolic composition (solid vs. gaseous) was analyzed 
manually for the first time and was balanced. The impact of MESs 
and TESs on neurological outcome needs to be evaluated further.
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